Nano-X Imaging Ltd. Announces Pricing of a $8 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Nano-X Imaging Ltd. (Nasdaq: NNOX), an innovative player in the medical imaging technology sector, has announced a securities purchase agreement with a long-term institutional investor to raise $8 million. The deal, which was disclosed on August 6, 2026, involves the sale of 8,000,000 Ordinary Shares and warrants to purchase an additional 8,000,000 Ordinary Shares at a combined purchase price of $1.00 per share. The warrants will have an exercise price of $1.15 per share and will be exercisable six months post-issuance, expiring five years from the closing date. The transaction is expected to close on or about August 7, 2026, pending customary closing conditions.

Nano-X Imaging is focused on transforming healthcare through its advanced medical imaging solutions, which aim to facilitate preventive healthcare. The company’s offerings include a comprehensive platform that integrates affordable imaging hardware, AI-based analytics, cloud-based software, and remote radiology services. By leveraging proprietary digital X-ray technology, Nano-X seeks to enhance the efficiency of routine imaging workflows, thereby supporting early disease detection and improving patient outcomes. The funds raised from this offering will be directed towards working capital and general corporate purposes, which are crucial for sustaining its growth trajectory.

The strategic rationale behind this fundraising effort aligns with the broader trends in the healthcare sector, particularly the growing emphasis on preventive care and early diagnosis. As healthcare systems worldwide increasingly prioritize cost-effective and efficient solutions, Nano-X's integrated approach positions it well to capture market share. The company's innovative imaging systems, such as the Nanox.ARC, are designed for scalability and ease of use, making them attractive options for both traditional hospital settings and emerging healthcare environments.

The medical imaging sector is witnessing significant advancements, driven by technological innovations and the integration of AI. Companies like Nano-X are at the forefront of this evolution, leveraging cutting-edge technology to improve clinical efficiency and access to care. As the market continues to evolve, the demand for affordable and effective imaging solutions is expected to rise, creating opportunities for growth for companies that can deliver on these fronts.

In conclusion, the successful completion of this $8 million fundraising will bolster Nano-X Imaging's capabilities to expand its product offerings and enhance its market position. As the healthcare landscape shifts towards preventive care and technological integration, Nano-X is well-positioned to capitalize on these trends, potentially influencing the future of medical imaging and healthcare delivery. The implications of this transaction extend beyond Nano-X, reflecting broader market dynamics that favor innovation and accessibility in healthcare solutions.